Alexanders INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NYSE
Alexander's, Inc. has finalized the sale of its Rego Park I shopping center in Queens to Northwell Health for $235.5 million.
NYSE
Alexanders, Inc. stockholders approved the 2026 Omnibus Stock Plan and re-elected three directors at the annual meeting, with strong support for executive compensation and auditor ratification.
NYSE
Alexanders Inc. subsidiary 731 Office One LLC amended its lease with Bloomberg L.P., providing a $56.8 million rent abatement offset by a reduction in Bloomberg's tenant improvement fund, and simultaneously adjusted its loan agreement to establish a free rent reserve account.
NYSE
Alexanders, Inc. has successfully restructured its $300 million mortgage loan on the 731 Lexington Avenue retail condominium, extending its maturity to December 2035.
NYSE
Alexanders, Inc. has completed a $175 million refinancing of its Rego Park II shopping center, extending its loan maturity to December 2030.
NYSE
Alexanders Inc. successfully held its 2025 Annual Meeting of Stockholders, reelecting two directors and ratifying its independent auditor.
NYSE
Alexanders Inc. reports the resignation of Dr. Richard West from the Board of Directors due to health reasons, effective January 1, 2025, leading to changes in committee leadership and board size.
NYSE
Alexanders Inc. has successfully refinanced its 731 Lexington Avenue office condominium with a new $400 million loan at a fixed interest rate of 5.045%, replacing a previous loan with a higher variable rate.
NYSE
Alexanders Inc.'s subsidiary, 731 Office One LLC, has extended the maturity of its $500 million mortgage loan on the 731 Lexington Avenue property to October 11, 2024, while also making a $10 million principal payment.
NYSE
Alexanders Inc. successfully held its 2024 Annual Meeting of Stockholders, re-electing three directors and ratifying its independent accounting firm.